Aspect Biosystems

Aspect Biosystems

HQ Country
Canada
Profile
Aspect Biosystems Ltd. is a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering. Aspect's proprietary Lab-on- a-Printerâ„¢ platform technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to create physiologically and commercially relevant tissues. These tissues are used to advance and accelerate drug discovery and development, and enable the creation of cutting-edge tissue therapies of the future.
Filtered by:
Aspect Biosystems
Company
Topic
Show
 
2020
9 Jun 2020

3D Bioprinted Organs in the Discovery and Development of Medicines

3D bioprinting provides scientists with the unique ability to create artificial tissue that closely resembles native tissue in form and function. A method of tissue engineering, 3D bioprinting is the precise deposition of cells, typically layer-by-layer, to realize a final 3D construct. Over the years, 3D bioprinting has seen increased adoption as a research tool and as a method for tissue engineering in regenerative medicine.
2018
12 Oct 2018

3D Printing in the Medical and Dental Industry 2019 - 2029

IDTechEx Report: Dr Bryony Core and Dr Nadia Tsao
13 Mar 2018

3D Bioprinting 2018 - 2028: Technologies, Markets, Forecasts

IDTechEx Report: Dr Nadia Tsao
2017
13 Dec 2017

Report on IDTechEx Show! USA 2017

The following article summarises some of the key observations made by IDTechEx analysts during the IDTechEx Show! It contains details of many of the companies demonstrating products during the exhibition, notable presentations given and summaries of relevant conversations and recent updates.
16 Nov 2017

Human Tissues On Demand With Next Generation 3D Bioprinting

Aspect Biosystems, Canada
10 Nov 2017

Tissue Engineering 2018-2028: Technologies, Markets, Forecasts

IDTechEx Report: Dr Nadia Tsao
19 Apr 2017

Aspect Biosystems

IDTechEx analyst Nadia Tsao interviewed Aspect Biosystems' Tamer Mohamed and Thomas Lum on 16 June, 2017. Aspect Biosystems is a Canadian 3D bioprinting company developing a proprietary lab-on-a-printer technology.
Included are: